Clinically, higher TIL numbers have been associated with improved survival in multiple solid tumor types [86,87,88]. Within TILs, cytotoxic CD8+ T lymphocytes are the effector cells, and their presence within the tumor may suggest checkpoint inhibitor efficacy. The gene discussed is CD8A; the disease is neoplasm.